Sarepta executes licensing agreement for gene therapy program in muscular dystrophy
August 04 2021 - 8:40AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Apr 2023 to Apr 2024